Re: Game changer? Is trypanophobia a thing of the past?
|
|
Mannkind
|
Feb 05, 2013 10:37AM
|
Re: MannKind Corporation to Hold 2012 Fourth Quarter...
|
|
Mannkind
|
Feb 05, 2013 07:36PM
|
Re: AFREZZUSER
|
|
Mannkind
|
Feb 07, 2013 02:06PM
|
MannKind v Rea
|
|
Mannkind
|
Feb 08, 2013 05:12PM
|
Re: MannKind v Rea
|
|
Mannkind
|
Feb 08, 2013 05:22PM
|
Re: Updated Share Price Model
|
1
|
Mannkind
|
Feb 09, 2013 08:48PM
|
Re: Happy to see they are protecting their intellectual property!
|
1
|
Mannkind
|
Feb 09, 2013 09:21PM
|
Re: Updated Share Price Model
|
|
Mannkind
|
Feb 10, 2013 09:44AM
|
Re: CC Notes
|
|
Mannkind
|
Feb 11, 2013 08:33PM
|
Transcript now available
|
1
|
Mannkind
|
Feb 12, 2013 10:02AM
|
Why No One Cares About MannKind's Earnings
|
|
Mannkind
|
Feb 12, 2013 01:04PM
|
Zacks
|
|
Mannkind
|
Feb 13, 2013 03:09PM
|
3 Events Biotech Investors Need to Watch in 2013
|
1
|
Mannkind
|
Feb 13, 2013 04:18PM
|
Re: CC Notes / Financing and Partnership Discussion
|
|
Mannkind
|
Feb 14, 2013 10:01AM
|
Winners After Novo Nordisk’s Insulin Rejection
|
5
|
Mannkind
|
Feb 14, 2013 10:53AM
|
Is MannKind in Good Hands?
|
1
|
Mannkind
|
Feb 15, 2013 10:12PM
|
1 Event Eli Lilly Investors Must Watch
|
1
|
Mannkind
|
Feb 15, 2013 10:19PM
|
Job opening
|
1
|
Mannkind
|
Feb 16, 2013 09:32AM
|
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
|
1
|
Mannkind
|
Feb 18, 2013 09:09AM
|
Method of preventing adverse effects by GLP-1
|
2
|
Mannkind
|
Feb 19, 2013 12:46PM
|